Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: We hould know something in less than 17 days----------------...

You guys are approaching this as if a potential buyer has been guaranteed revenue from the MMP. I think thats a lofty presumption considering a new buyer would face the same challenges that currently plague TPL. I can agree with the theory that a potential new partnership may be underway but a buyout is very unlikely, IMO. Not to mention, once again, does TPL have the authority to bring in new partners? How would MMP revenue be split, in quarters? Patriot, TPL, Chuck Moore and XXXX?

Share
New Message
Please login to post a reply